Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Shareholders' Equity (Deficit)

v3.21.2
Condensed Consolidated Statement of Changes in Shareholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Preferred Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Beginning Balance at Dec. 31, 2019 $ (177,193) $ 698,452 $ 4,945 $ (182,122) $ (28)
Beginning Balance (In Shares) at Dec. 31, 2019   121,537,571 320,181,375      
Net loss (25,361)       (25,361)  
Stock-based compensation expense 850     850    
Issuance of redeemable convertible preferred stock, net of issuance costs     $ 45,488      
Issuance of common stock upon exercise of stock options, Shares   84,023        
Issuance of common stock upon exercise of stock options 17     17    
Issuance of common stock upon the reverse recapitalization, net of issuance costs, Shares     8,210,082      
Repurchase of common stock, Shares   (55,463)        
Vesting of early exercised stock options 104     104    
Other Comprehensive Income (Loss) (570)         (570)
Ending Balance at Mar. 31, 2020 (202,153) $ 743,940 5,916 (207,483) (598)
Ending Balance (In Shares) at Mar. 31, 2020   121,566,131 328,391,457      
Beginning Balance at Dec. 31, 2019 (177,193) $ 698,452 4,945 (182,122) (28)
Beginning Balance (In Shares) at Dec. 31, 2019   121,537,571 320,181,375      
Net loss (80,265)          
Ending Balance at Sep. 30, 2020 (251,507) $ 768,312 9,905 (262,387) 963
Ending Balance (In Shares) at Sep. 30, 2020   121,736,591 332,764,215      
Beginning Balance at Mar. 31, 2020 (202,153) $ 743,940 5,916 (207,483) (598)
Beginning Balance (In Shares) at Mar. 31, 2020   121,566,131 328,391,457      
Net loss (26,876)       (26,876)  
Issuance of redeemable convertible preferred stock, Shares     4,372,758      
Stock-based compensation expense 1,815     1,815    
Issuance of redeemable convertible preferred stock, net of issuance costs     $ 24,372      
Issuance of common stock upon exercise of stock options, Shares   233,810        
Issuance of common stock upon exercise of stock options 47     47    
Repurchase of common stock (1)     (1)    
Repurchase of common stock, Shares   (131,681)        
Vesting of early exercised stock options 82     82    
Other Comprehensive Income (Loss) 1,884         1,884
Ending Balance at Jun. 30, 2020 (225,202) $ 768,312 7,859 (234,359) 1,286
Ending Balance (In Shares) at Jun. 30, 2020   121,668,260 332,764,215      
Net loss (28,028)       (28,028)  
Stock-based compensation expense 1,974     1,974    
Issuance of common stock upon exercise of stock options, Shares   68,331        
Issuance of common stock upon exercise of stock options 19     19    
Vesting of early exercised stock options 53     53    
Other Comprehensive Income (Loss) (323)         (323)
Ending Balance at Sep. 30, 2020 (251,507) $ 768,312 9,905 (262,387) 963
Ending Balance (In Shares) at Sep. 30, 2020   121,736,591 332,764,215      
Beginning Balance at Dec. 31, 2020 (283,168) $ 12 $ 768,312 12,579 (296,286) 527
Beginning Balance (In Shares) at Dec. 31, 2020   122,058,940 332,764,215      
Net loss (41,505)       (41,505)  
Issuance of redeemable convertible preferred stock, Shares     8,924,010      
Stock-based compensation expense 4,808     4,808    
Other non-cash compensation expense 1,741     1,741    
Issuance of redeemable convertible preferred stock     $ 77,619      
Issuance of common stock upon exercise of stock options, Shares   746,830        
Issuance of common stock upon exercise of stock options 303     303    
Vesting of early exercised stock options 75     75    
Other Comprehensive Income (Loss) (309)         (309)
Ending Balance at Mar. 31, 2021 (318,055) $ 12 $ 845,931 19,506 (337,791) 218
Ending Balance (In Shares) at Mar. 31, 2021   122,805,770 341,688,225      
Beginning Balance at Dec. 31, 2020 (283,168) $ 12 $ 768,312 12,579 (296,286) 527
Beginning Balance (In Shares) at Dec. 31, 2020   122,058,940 332,764,215      
Net loss (185,369)          
Ending Balance at Sep. 30, 2021 1,304,671 $ 60   1,786,118 (481,655) 148
Ending Balance (In Shares) at Sep. 30, 2021   604,335,426        
Beginning Balance at Mar. 31, 2021 (318,055) $ 12 $ 845,931 19,506 (337,791) 218
Beginning Balance (In Shares) at Mar. 31, 2021   122,805,770 341,688,225      
Net loss (65,006)       (65,006)  
Issuance of redeemable convertible preferred stock, Shares     2,677,200      
Stock-based compensation expense 6,992     6,992    
Other non-cash compensation expense 2,006     2,006    
Issuance of common stock upon exercise of stock options, Shares   592,948        
Issuance of common stock upon exercise of stock options 217     217    
Vesting of early exercised stock options 112     112    
Other Comprehensive Income (Loss) 38         38
Ending Balance at Jun. 30, 2021 (373,696) $ 12 $ 845,931 28,833 (402,797) 256
Ending Balance (In Shares) at Jun. 30, 2021   123,398,718 344,365,425      
Net loss (78,858)       (78,858)  
Stock-based compensation expense 7,618     7,618    
Other non-cash compensation expense 2,028     2,028    
Issuance of common stock upon exercise of stock options, Shares   699,852        
Issuance of common stock upon exercise of stock options 347     347    
Issuance of common stock upon exercise of SVB warrants   752,732        
Issuance of redeemable convertible preferred stock upon exercise of In-Q-Tel warrants, Shares     68,629      
Issuance of redeemable convertible preferred stock value upon exercise of In-Q-Tel warrants 691     691    
Issuance of common stock upon conversion of Uber convertible notes, Shares   7,716,780        
Issuance of common stock upon conversion of Uber convertible notes 77,399 $ 1   77,398    
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization, Shares   344,434,054 (344,434,054)      
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization 845,931 $ 34 $ (845,931) 845,897    
Issuance of common stock upon the reverse recapitalization, net of issuance costs, Shares   127,333,290        
Issuance of common stock upon the reverse recapitalization, net of issuance costs 823,269 $ 13   823,256    
Vesting of early exercised stock options 50     50    
Other Comprehensive Income (Loss) (108)         (108)
Ending Balance at Sep. 30, 2021 $ 1,304,671 $ 60   $ 1,786,118 $ (481,655) $ 148
Ending Balance (In Shares) at Sep. 30, 2021   604,335,426